suplatast tosilate has been researched along with Allergic Reaction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, T; Das, AK; Fukui, H; Kadota, T; Kitamura, Y; Kominami, T; Kosaka, T; Matsumoto, M; Miyagi, K; Mizuguchi, H; Orimoto, N; Sawada, A; Takeda, N; Tamada, M | 1 |
Capron, M; Chihara, J; Decot, V; Loiseau, S; Loyens, M; Ono, N; Woerly, G | 1 |
Koda, A; Matsuura, N; Yanagihara, Y | 1 |
3 other study(ies) available for suplatast tosilate and Allergic Reaction
Article | Year |
---|---|
Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Calcineurin; Cells, Cultured; Drug Therapy, Combination; Gene Expression; Histamine Antagonists; Hypersensitivity; Interleukin-9; Male; NFATC Transcription Factors; Nose Diseases; Rats; Receptors, Histamine H1; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate | 2016 |
CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Topics: Anti-Allergic Agents; Arylsulfonates; CD28 Antigens; Chemokine CCL11; Chemokines, CC; Chemotaxis, Leukocyte; Cytokines; Eosinophil Cationic Protein; Eosinophil-Derived Neurotoxin; Eosinophilia; Eosinophils; Humans; Hypersensitivity; Immunoglobulin A, Secretory; Interleukin-5; N-Formylmethionine Leucyl-Phenylalanine; Oxidation-Reduction; Reactive Oxygen Species; Sulfonium Compounds | 2004 |
IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
Topics: Animals; Antibodies; Antibody Formation; Arylsulfonates; Asthma; B-Lymphocytes; Dermatitis, Atopic; Female; Hypersensitivity; Immunoglobulin E; Interleukin-4; Mice; Mice, Inbred BALB C; Receptors, Fc; Sulfonium Compounds | 1991 |